case_images: PMC10853330_01
case_images: Photograph of intravenous implanted treprostinil pump. The silicone membrane where treprostinil is injected is marked with arrows.
case_images: fcvm-11-1348311-g001.jpg
case_images: PMC10853330_01_fcvm-11-1348311-g001.jpg
case_images: F1
case_images: A nurse from the Pulmonary Vascular Unit trained to fill the pump in a sterile environment proceeded to manually locate the silicone port on the top of the device (Figure 1).
case_images: Erythematous and oedematous area around the subcutaneous pump.
case_images: fcvm-11-1348311-g002.jpg
case_images: PMC10853330_01_fcvm-11-1348311-g002.jpg
case_images: F2
case_images: Physical examination revealed generalized vasodilation, with an erythematous and edematous area around the subcutaneous pump (Figure 2).
case_images: Abdominal incisions around the subcutaneous pump, 7 days later.
case_images: fcvm-11-1348311-g003.jpg
case_images: PMC10853330_01_fcvm-11-1348311-g003.jpg
case_images: F3
case_images: Also, incision and drainage of the injection site was performed to remove the treprostinil, with no clinical improvement (Figure 3).
case_images: Trends in catecholamines and restart of pulmonary arterial hypertension treatment.
case_images: fcvm-11-1348311-g004.jpg
case_images: PMC10853330_01_fcvm-11-1348311-g004.jpg
case_images: F4
case_images: One day later, sildenafil and bosentan were gradually re-introduced (Figure 4).